News

North Carolina State University announced that the National Institute for Occupational Safety and Health (NIOSH) will resume its "health hazard evaluation" into a potential cancer cluster at Poe Hall, ...
Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the ...
Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...
To help prepare for the fight ahead, we invite you to apply for the ACLU National Advocacy Institute’s High School Program. This one-week program will be offered three times this summer: Session 1: ...
AN INFECTIOUS DISEASE SPECIALIST AT SOUTH SHORE HEALTH ... of medical visits and use of specific medications based on national insurance records, Lee said.Still, some variables, like diet ...
“This study supports a broader understanding of vaccination — not just as a shield against infectious diseases ... of specific medications based on national insurance records, Lee said.Still ...
Learn more about whether ACADIA Pharmaceuticals Inc. or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Funding Funding for the study was obtained from the Cystic Fibrosis Foundation (award no RATJEN16A0), Cystic Fibrosis Canada (Grant ID: 3187) and the Cystic Fibrosis Foundation Therapeutics ...
North India’s first AI-enabled PET-CT scanner launched in Gurugram The system offers accurate scans with 60% less radiation exposure The new scanner will also support ongoing cancer research For ...
So skip them if your BP is high or if you have heart disease. Bottom line? If you're on any medication, get your doctor’s OK before you try an over-the-counter cough treatment.
Just off South Carolina's coast is a Lowcountry island populated almost entirely by rhesus monkeys, too bad only monkeys are allowed on the island.
President Donald Trump on Monday signed an executive order banning federal funding for “gain of function” research on pathogens in some foreign laboratories, the latest signal that the White House and ...